Literature DB >> 28424949

Aggressive Crosstalk Between Fatty Acids and Inflammation in Macrophages and Their Influence on Metabolic Homeostasis.

Kazuhiro Nishiyama1, Yasuyuki Fujimoto1, Tadayoshi Takeuchi1, Yasu-Taka Azuma2.   

Abstract

From the immunological point of view, macrophages are required to maintain metabolic homeostasis. Recently, there has been an increased focus on the influence of macrophage phenotypes in adipose tissue on the maintenance of metabolic homeostasis in healthy conditions because dysregulated metabolic homeostasis causes metabolic syndrome. This review notes several types of inflammatory and anti-inflammatory mediators in metabolic homeostasis. M1 macrophage polarization mediates inflammation, whereas M2 macrophage polarization mediates anti-inflammation. Fatty acids and their related factors mediate both inflammatory and anti-inflammatory responses. Saturated fatty acids and polyunsaturated fatty acids mediate inflammation, whereas marine-derived n-3 fatty acids, such as eicosapentaenoic acid and docosahexaenoic acid, mediate anti-inflammation. In this review, we discuss the current understanding of the crosstalk between fatty acids and inflammation in macrophages and their influence on metabolic homeostasis.

Entities:  

Keywords:  Anti-inflammation; Crosstalk; Fatty acid; Inflammation; Macrophage; Metabolic disease

Mesh:

Substances:

Year:  2017        PMID: 28424949     DOI: 10.1007/s11064-017-2269-x

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  104 in total

1.  Prevalence and characteristics of the metabolic syndrome in the San Antonio Heart and Framingham Offspring Studies.

Authors:  James B Meigs; Peter W F Wilson; David M Nathan; Ralph B D'Agostino; Ken Williams; Steven M Haffner
Journal:  Diabetes       Date:  2003-08       Impact factor: 9.461

2.  Epidermal Fatty Acid binding protein promotes skin inflammation induced by high-fat diet.

Authors:  Yuwen Zhang; Qiang Li; Enyu Rao; Yanwen Sun; Michael E Grossmann; Rebecca J Morris; Margot P Cleary; Bing Li
Journal:  Immunity       Date:  2015-05-19       Impact factor: 31.745

Review 3.  Targeting GPR120 and other fatty acid-sensing GPCRs ameliorates insulin resistance and inflammatory diseases.

Authors:  Saswata Talukdar; Jerrold M Olefsky; Olivia Osborn
Journal:  Trends Pharmacol Sci       Date:  2011-06-12       Impact factor: 14.819

4.  Fatty acid-binding protein 5 limits the anti-inflammatory response in murine macrophages.

Authors:  Sherri M Moore; Vivian V Holt; Lillie R Malpass; Ian N Hines; Michael D Wheeler
Journal:  Mol Immunol       Date:  2015-06-20       Impact factor: 4.407

5.  Andrographolide derivative AL-1 improves insulin resistance through down-regulation of NF-κB signalling pathway.

Authors:  Yongmei Li; Hui Yan; Zaijun Zhang; Gaoxiao Zhang; Yewei Sun; Pei Yu; Yuqiang Wang; Lipeng Xu
Journal:  Br J Pharmacol       Date:  2015-04-10       Impact factor: 8.739

Review 6.  Role and function of macrophages in the metabolic syndrome.

Authors:  Prerna Bhargava; Chih-Hao Lee
Journal:  Biochem J       Date:  2012-03-01       Impact factor: 3.857

Review 7.  Fatty acid-binding proteins: role in metabolic diseases and potential as drug targets.

Authors:  Masato Furuhashi; Gökhan S Hotamisligil
Journal:  Nat Rev Drug Discov       Date:  2008-06       Impact factor: 84.694

8.  Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity.

Authors:  Jorge Henao-Mejia; Eran Elinav; Chengcheng Jin; Liming Hao; Wajahat Z Mehal; Till Strowig; Christoph A Thaiss; Andrew L Kau; Stephanie C Eisenbarth; Michael J Jurczak; Joao-Paulo Camporez; Gerald I Shulman; Jeffrey I Gordon; Hal M Hoffman; Richard A Flavell
Journal:  Nature       Date:  2012-02-01       Impact factor: 49.962

Review 9.  Role of the Toll Like receptor (TLR) radical cycle in chronic inflammation: possible treatments targeting the TLR4 pathway.

Authors:  Kurt Lucas; Michael Maes
Journal:  Mol Neurobiol       Date:  2013-02-26       Impact factor: 5.590

10.  JNK expression by macrophages promotes obesity-induced insulin resistance and inflammation.

Authors:  Myoung Sook Han; Dae Young Jung; Caroline Morel; Saquib A Lakhani; Jason K Kim; Richard A Flavell; Roger J Davis
Journal:  Science       Date:  2012-12-06       Impact factor: 47.728

View more
  6 in total

Review 1.  Nutrigenomics of Dietary Lipids.

Authors:  Laura Bordoni; Irene Petracci; Fanrui Zhao; Weihong Min; Elisa Pierella; Taís Silveira Assmann; J Alfredo Martinez; Rosita Gabbianelli
Journal:  Antioxidants (Basel)       Date:  2021-06-22

2.  Systematisation of biological protectors for managing the metabolic syndrome development.

Authors:  Valery V Benberin; Ainur S Sibagatova; Almagul A Nagimtayeva; Kamshat M Akhmetova; Tamara A Voshchenkova
Journal:  J Diabetes Metab Disord       Date:  2021-08-25

Review 3.  Dry Eye Management: Targeting the Ocular Surface Microenvironment.

Authors:  Xiaobo Zhang; Vimalin Jeyalatha M; Yangluowa Qu; Xin He; Shangkun Ou; Jinghua Bu; Changkai Jia; Junqi Wang; Han Wu; Zuguo Liu; Wei Li
Journal:  Int J Mol Sci       Date:  2017-06-29       Impact factor: 5.923

4.  Acute high-fat feeding leads to disruptions in glucose homeostasis and worsens stroke outcome.

Authors:  Michael J Haley; Siddharth Krishnan; David Burrows; Leon de Hoog; Jamie Thakrar; Ingo Schiessl; Stuart M Allan; Catherine B Lawrence
Journal:  J Cereb Blood Flow Metab       Date:  2017-11-24       Impact factor: 6.200

5.  Changes in peripheral blood compounds following psychopharmacological treatment in drug-naïve first-episode patients with either schizophrenia or major depressive disorder: a meta-analysis.

Authors:  Nuray Çakici; Arjen L Sutterland; Brenda W J H Penninx; Lieuwe de Haan; Nico J M van Beveren
Journal:  Psychol Med       Date:  2021-03-03       Impact factor: 7.723

Review 6.  Pattern Recognition Receptor-Mediated Chronic Inflammation in the Development and Progression of Obesity-Related Metabolic Diseases.

Authors:  Lili Yu; Yanhua Li; Cancan Du; Weidong Zhao; Hanxiao Zhang; Yun Yang; Aiping Sun; Xiangfeng Song; Zhiwei Feng
Journal:  Mediators Inflamm       Date:  2019-09-08       Impact factor: 4.711

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.